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TFAP2B	affected	all	 three	scales	of	 the	SCL-	90R	 inventory	 in	BN	patients	 (p	≤	.01).	
Epistasis	analyses	revealed	relevant	interactions	with	body	mass	index	of	BN	patients	
(p	<	.001).	Genetic	 profiles	 in	 obese	patients	 did	 not	 significantly	 differ	 from	 those	
found	in	ED	patients.








Eating	 disorders	 (ED)	 are	 complex	 psychiatric	 disorders	 that	 have	 
become the third most chronic disease among young females in west-
ern	 societies	 (Herpertz-	Dahlmann,	2009).	 It	 is	 now	widely	 accepted	
that	genetic	factors	are	involved	in	the	etiology	of	ED	and	many	asso-
ciation studies in this regard have been carried out in the last decade 
(Clarke,	Weiss,	&	Berrettini,	 2012;	Hinney	&	Volckmar,	 2013;	Rask-	
Andersen,	Olszewski,	Levine,	&	Schioth,	2010).	However,	it	is	striking	
that the majority of genes involved in the central regulation of food 
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intake,	such	as	those	recently	evidenced	by	genome-	wide	association	
studies	 (GWAS)	and	 follow-	up	 studies	 in	obese	 individuals	 (Waalen,	
2014),	have	not	yet	been	explored	in	the	ED	setting.	Two	such	genes	
are	 the	Transcription	Factor	AP-	2	Beta	 (TFAP2B)	 and	 the	Potassium	
Channel	Tetramerization	Domain	Containing	15	(KCTD15).
The	 transcription	 factor	 AP-	2	 family	 encodes	 critical	 regulatory	
factors	 for	neural	 gene	expression	and	development	 that	 also	exert	
a	tight	regulation	of	monoaminergic	genes	(Damberg,	2005).	There	is	
a	polymorphic	region	(rs370476693)	in	the	second	intron	of	TFAP2B 
gene	 consisting	 of	 a	 variable	 number	 of	 [CAAA]	 repeats	 of	 four	 or	
five	 times,	 with	 less	 number	 of	 repeats	 associated	 with	 increased	
gene	expression	(Ivorra	et	al.,	2011).	This	polymorphism	has	been	re-
lated to different personality dimensions in women and adolescents 




The KCTD15 gene is a member of the KCTD family with an antag-
onist	 role	 in	neural	crest	 formation	 (Dutta	&	Dawid,	2010;	Zarelli	&	
Dawid,	2013).	A	number	of	GWAS	have	identified	SNPs	in	or	near	de	
KCTD15	 gene	as	putative	 regulators	of	body	mass	 index	 (BMI)	 (Mei	
et	al.,	2012;	Paternoster	et	al.,	2011;	Thorleifsson	et	al.,	2009;	Willer	
et	al.,	2009).	 Interestingly,	there	is	recent	evidence	in	animal	models	
that TFAP2B and KCTD15 homologues co- localize in areas of the brain 
where	they	interact	to	regulate	feeding	behavior	and	reward	(Williams	
et	al.,	2014)	(Figure	1).
Genetic	alterations	 in	 the	complex	neural	 system	aimed	 to	keep	
energy balance by food intake are known to trigger and maintain obe-
sity,	but	 the	genes	 involved	 in	 the	neuronal	 control	of	weight	 regu-
lation	might	also	be	relevant	for	ED	(Day,	Ternouth,	&	Collier,	2009;	
Gervasini	 &	 Gamero-	Villarroel,	 2015).	 Indeed,	 we	 and	 others	 have	
shown	that	variability	in	these	genes	is	also	associated	with	ED-	related	
behaviors	 (Gamero-	Villarroel	 et	al.,	 2014,	 2015;	Muller	 et	al.,	 2012;	
Rybakowski	et	al.,	2007).	According	 to	 this	background,	we	hypoth-
esized in the present work that TFAP2B and KCTD15	variants,	either	
isolated	 or	 in	 combination,	may	 influence	 personality	 dimensions	 in	
anorexia	nervosa	 (AN)	or	bulimia	nervosa	 (BN)	patients.	We	also	 in-







One-	hundred	 and	 sixty-	nine	 unrelated	 consecutive	 female	 patients	
with	 ED	 (AN	=	106,	 BN	=	63),	 participated	 in	 the	 study.	 The	 pa-
tients	attended	the	collaborating	Eating	Disorders	Unit	at	the	Mental	
Health	Outpatient	Clinic	 in	Badajoz	 (Spain),	 and	were	diagnosed	by	





were	 collected.	Diagnosis	was	blind	 to	 genotype.	Exclusion	 criteria,	
determined	 upon	 screening,	 included	 dementia,	mental	 retardation,	




that they had never been diagnosed as having any psychiatric disorder 
or	 received	 any	psychiatric	 treatment.	All	 these	 individuals	 showed	
normal	BMI	values	and	had	no	history	of	ED.	Finally,	a	group	of	75	
female	obese	patients	with	no	ED,	 recruited	among	patients	of	 the	
Infanta	Cristina	University	Hospital	 in	Badajoz	 (Spain)	was	 included	
for comparison purposes. These subjects were selected from families 
from	the	same	region	as	the	ED	patients	that	were	studied	to	detect	











allow it to induce catecholamines signaling 
to	trigger	an	orexigenic	signal	that	would	
eventually lead to consummatory behavior
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>3 standard deviations above the mean before 14 years of age and 









European	 population	 (CEU)	 single-	nucleotide	 polymorphism	 (SNP)	
data	 were	 downloaded	 from	 the	 1000	 Genome	 website	 (https://
www.ncbi.nlm.nih.gov/variation/tools/1000genomes/).	We	analyzed	
the	coding	sequence	and	adjacent	3′-	and	5′-	untranslated	regions	of	
the TFAP2B and KCTD15	genes	(ref.	NC_000006.12,	NC_000019.10)	
and	 tag	 SNPs	 were	 assigned	 using	 Haploview	 v4.2	 software	 (Daly	
Lab	at	the	Broad	Institute,	Cambridge,	MA,	USA;	Table	1).	The	minor	




the	 same	 linkage	disequilibrium	block	 (r2	 values	 ranged	 from	 .52	 to	
1.0)	and	captured	100%	of	the	variability	of	both	genes.	All	the	SNPs	
were	 intronic	and	 located	within	an	18,595-	kb	region	 (chromosome	
positions	50828921–50847516)	and	12,882-	kb	region	(chromosome	
positions	33799262–33812144)	encompassing	the	TFAP2B gene and 
KCTD15	gene,	respectively.






Blood samples from all participants were collected and stored 
at	−80°C	until	analysis.	Genomic	DNA	was	 isolated	 from	peripheral	
blood	 leukocytes	 in	 2-	ml	 aliquots	 of	 whole-	blood	 samples	 with	 a	
Qiagen	 blood	midi	 kit	 (Qiagen,	 Chatsworth,	 CA,	USA).	 The	 purified	
DNA	samples	were	then	stored	at	4°C	in	sterile	plastic	vials.	Genotype	
analyses	 for	 SNPs	 determination	 were	 performed	 with	 the	 single-	
base	 extension	 polymerase	 chain	 reaction	 Sequenom	 iPLEX-	Gold	
and	the	mass	spectrometry-	based	platform	MassARRAY	MALDI-	TOF	
(Sequenom,	San	Diego,	CA,	USA)	at	the	Spanish	Genotyping	National	
Centre	 (CEGEN-	ISCIII).	 In	 brief,	 the	 analyses	 consisted	 of	 an	 initial	
locus	 specific	 PCR,	 followed	 by	 single-	base	 extension	 using	 mass-	
modified	dideoxynucleotide	terminators	of	an	oligonucleotide	primer,	




rs552393576	polymorphisms	in	the	TAFP2B gene were genotyped by 
direct	sequencing	in	the	same	reaction.	Primers	and	PCR	conditions	
are	available	upon	request.





sess	 ED-	related	 cognitive	 and	 behavioral	 characteristics	 by	 initially	






the	 different	 subscales	 (Guimera	 &	 Torrubia,	 1987).	 The	 Symptom	









ried out using logistic regression models adjusted for age using the 
SNPassoc	 R	 package	 (Gonzalez	 et	al.,	 2007).	 Statistical	 significance	
threshold	after	correcting	for	the	10	SNPs	assayed	was	set	at	0.005.	
For	 the	 multiple-	marker	 analysis,	 the	 p- value was adjusted by the 
TABLE  1 Selected	single-	nucleotide	polymorphisms	in	the	
regions encompassing the TFAP2B and KCTD15 genes
Polymorphism Positiona Region Alelles MAF
TFAP2B
rs760900 6:50828921 Intronic C/T 0.432
rs2817420 6:50845619 3′-	UTR C/T 0.179
rs7769978 6:50847516 3′-	UTR C/T 0.105
rs552393576 6:50823879 Intronic A/G 0.192
rs370476693 6:50823893-	6 Intronic [CAAA]/-	 0.476
KCTD15
rs736239 19:33799262 Intronic G/C 0.412
rs287103 19:33801816 Intronic C/T 0.335
rs4239577 19:33803962 Intronic C/T 0.319
rs4805059 19:33803996 Intronic G/A 0.483
rs2056180 19:33812144 3′-	UTR T/C 0.097
MAF,	minor	allele	frequency;	UTR,	untranslated	region.
aReference	assembly	GRCh38.
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number of haplotypes identified in the population. The number of 
psychopathological scales analyzed was not included in the adjust-
ment,	as	previous	studies	in	ED	patients	have	claimed	this	would	be	
too stringent to detect moderate associations with different endophe-
notypes	(Gamero-	Villarroel	et	al.,	2014,	2015;	Mercader	et	al.,	2007).	
Haplotype	associations	were	performed	with	the	haplo.stats	package,	
also	 in	 the	R	 environment.	Gene–gene	 interaction	 (epistasis)	 analy-
ses were performed using log- likelihood ratio tests adjusted by age 
(SNPassoc	package)	in	a	codominant	model.	In	the	resulting	plots,	the	
diagonal line contains the p- values from likelihood ratio test for the 
crude	effect	of	each	SNP,	which	are	sorted	by	their	genomic	position.	





Clinical and descriptive characteristics of healthy subjects and obese 
and	 ED	 patients	 are	 summarized	 in	 Table	2.	 Control	 subjects	 dis-
played	significantly	higher	weight	and	BMI	than	AN	patients	(p	<	.05).	
Likewise,	 obese	 individuals	 had	higher	weight	 and	BMI	 than	 all	 the	
other	groups,	including	BN	patients	(p < 10−5).	In	addition,	BN	patients	
scored	 significantly	 higher	 than	 AN	 patients	 in	 the	 different	 scales	
measured	in	the	psychometric	evaluation	(Table	2).
3.1 | Single- marker analyses
Minor	allelic	 frequencies	 for	 the	polymorphisms	assayed	are	shown	
in	Table	1.	Note	that	 the	TFAP2B rs2272903 polymorphism did not 
survive	 quality-	control	 with	 the	 genotyping	 methods	 utilized	 and	
hence it could not be analyzed. The rs287103 T variant allele in the 
KCTD15	gene	was	significantly	associated	with	increased	risk	of	BN,	






GSI	 index	 in	 the	 SCL-	90R	questionnaire,	 although	 statistical	 signifi-
cance	did	not	survive	correction	by	multiple	testing	(Table	3).	 In	the	
AN	patients,	rs552393576	and	rs2817420	in	TFAP2B	and	rs4805059	
and	 rs4239577	 in	 KCTD15 showed relevant associations with the 
scores	of	several	dimensions	(Table	4).	Also	 in	the	106	AN	patients,	
the	 rs760900	 T	 variant	 in	 TFAP2B was found to correlate with 
BMI	 [mean	BMI	 (standard	 error)	 for	 CC	 vs.	 CT+TT	 carriers	=	17.87	
(0.33)	 and	16.81	 (0.24);	p < .01; r-	square	 value	 for	 the	 influence	 of	
the	regression	model	containing	rs760900	and	age	on	BMI	variabil-
ity	=	0.114].	However,	after	correction	by	multiple	testing,	 the	 level	
of association decreased to a statistical trend.
3.2 | Multiple- marker analyses
The	 frequencies	 of	 haplotypes	 identified	 in	 the	 different	 groups	
of	 study	 and	 linkage	 disequilibrium	 information	 are	 shown	 in	
Supplementary	Table	S1	and	Supplementary	Figure	S1,	respectively.	
Not	 all	 the	 possible	 allele	 combinations	were	 found	 in	 the	 popula-
tion.	Most	notably,	haplotype	*6	 in	KCTD15	 (GCTAC)	was	 far	more	
frequent	in	controls	than	in	any	other	study	group	(OR	=	0.42	[0.19–
0.94],	p	=	.03	for	the	comparison	with	BN	and	OR	=	0.40	[0.20–0.80],	
p	=	.009	 for	 the	comparison	with	AN).	Only	 this	 last	association	 re-





lotype *4	 (CCC[CAAA]4A)	 in	TFAP2B strongly affected the scores of 
all	three	scales	of	the	SCL-	90R	inventory	 in	BN	patients.	Regression	
analyses adjusted by age revealed that this haplotype combination 
AN BN Obese Controls
Age,	years 18.9	±	6.2 20.9 ± 8.1 35.23	±	14.11 33.09 ± 18.12
Height,	m 1.60	±	0.07 1.61	±	0.06 1.61	±	7.90 1.61	±	0.07
Weight,	kg 44.28	±	6.08 59.16	±	13.65 103.11	±	17.65*** 60.3	±	10.12*
BMI,	kg/m2 17.19 ± 2.01 22.71	±	5.03 39.63	±	6.27*** 22.06	±	5.17*
Age	at	onset,	yrs 16.9	±	4.8 17.8 ± 4.9
EDI-	2 88.84	±	45.53 117.27	±	39.14**
GSI	(SCL-	90R) 1.62	±	0.85 1.96	±	0.82§






**p < .001 and §p	<	.05	for	the	comparison	between	AN	and	BN	patients.
***p < 10−5 for the comparison between obese and the other patients groups.
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correlated	 with	 lower	 GSI,	 PST,	 and	 PSDI	 scores	 in	 these	 women.	
After	 correcting	 for	 the	 number	 of	 haplotypes,	 p- values retained 
significance	 in	 the	GSI	 and	 PSDI	 scales	 (Table	5).	 The	 effect	 of	 the	
KCTD15 haplotypes was more diffuse and associations did not survive 
Bonferroni	correction	of	the	data.	Haplotype	*2 was related to Drive 
for thinness	(mean	difference	with	95%	confidence	intervals	[CI]	=	3.25	
[0.73–5.76],	p	=	.011]	in	AN	patients.	In	the	BN	group,	two	haplotypes	

















tasis was more profound in scales such as Perfectionism,	Maturity fears 
or Social Insecurity	for	AN	patients,	while	in	BN	patients,	dimensions	
such as Interpersonal distrust or Social insecurity were found to show 
more hits.
TABLE  3 Relevant effects of TFAP2B and KCTD15	SNPs	on	
personality dimensions scores obtained for patients with Bulimia 
Nervosa
SNP % Mean diff. (CI) p
BD
rs7769978



















index;	 PSDI,	 positive	 symptom	 distress	 index;	 SNP,	 single-	nucleotide	
polymorphisms.
TABLE  4 Relevant effects of TFAP2B and KCTD15	SNPs	on	
personality	dimensions	scores	obtained	for	patients	with	anorexia	
nervosa
SNP % Mean diff. (CI) p
DT
rs552393576
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3.4 | Obese patients
Out	of	 the	eight	SNPs	assessed	 in	 the	obesity	and	control	groups,	
two	were	 associated	with	 obesity	 risk.	 The	 rs2056180	C	 allele	 of	
KCTD15	was	more	 frequent	 in	 controls	 (26.4%	of	 carriers)	 than	 in	
obese	 subjects	 (12.0%)	 (OR	=	0.38	 [0.18–0.82];	 p	=	.008).	 In	 con-
trast,	 the	 TFAP2B	 rs2817420	 T	 allele	 was	 present	 in	 29.9%	 of	
controls	 but	 45.3%	 of	 obese	 individuals	 (OR	=	1.94	 [1.11–3.39],	
p	=	.02).	 In	 any	 case,	 the	p- values were higher than the threshold 
established	for	statistical	significance	(0.001).	Interestingly,	this	last	
SNP,	rs2817420,	was	the	only	one	that	was	differently	distributed	
between	 ED	 patients	 and	 obese	 individuals	 (Supplementary	 Table	
S2).	As	it	occurred	in	BN	and	AN	patients,	haplotype	*6 in KCTD15 
was	significantly	 less	 frequent	 in	 the	obese	group	 than	 in	controls	
(Supplementary	Table	S1).
4  | DISCUSSION




of	 these	traits	are	 the	obvious	 result	of	 the	disease,	 it	 is	 likely	 that	
the	direction	of	causality	runs	both	ways.	Indeed,	psychopathological	
symptoms have been shown to alter eating behavior which in turn 
leads	 to	 obesity	 (Lee,	 2007).	 Two	 genes	 recently	 associated	 with	




alterations in central pathways involved in the modulation of eat-
ing	behavior	and	food	intake	that	may	lead	to	obesity,	could	also	be	
linked	to	ED.
Our results showed that the rs287103 T variant allele in the 
KCTD15	gene	was	not	only	associated	with	increased	risk	of	BN,	but	




findings	by	Brandys	et	al.	 (2010),	who	failed	 to	 find	a	significant	ef-




KCTD15 have repeatedly been associated with obesity in a number 
of	GWAS	and	replication	studies	(Mei	et	al.,	2012;	Paternoster	et	al.,	
2011;	Thorleifsson	et	al.,	2009;	Willer	et	al.,	2009).	The	cerebral	 lo-
cation of the gene indicates that its association with weight increase 
would	 likely	be	based	on	changes	 in	 feeding	behavior.	 Indeed,	a	 re-
cent study has confirmed an association of KCTD15	SNPs	and	dietary	
behaviors	 in	children	(Lv	et	al.,	2015)	and	another	report	has	related	
variant transcripts of KCTD15	to	fatness	traits	in	animals	(Liang	et	al.,	
2015).	According	to	our	findings,	it	seems	plausible	that	SNPs	in	this	
gene could also help develop aberrant conduct patterns that favor the 
establishment	of	ED,	should	other	susceptibility	factors	or	personal-
ity	dimensions	were	present.	Of	note,	both	SNPs	and	haplotypes	 in	
KCTD15 were associated in our sample with a number of traits that 
often	appear	coupled	with	ED.





patients	 in	 the	SCL-	90R	 inventory.	This	 inventory	measures	 general	
psychopathological symptoms that do not necessarily have to be inti-
mately	related	to	ED	and,	as	such,	would	be	more	typically	linked	to	BN	
than	AN	patients.	Some	of	the	mechanisms	underlying	the	different	
TABLE  5  Impact of TFAP2B	haplotypes	on	the	scores	of	the	SCL-	90R	inventory	in	patients	with	bulimia	nervosa
Haplotype
GSI PSDI PST
Mean diff 95% CI p- value Mean diff 95% CI p- value Mean diff 95% CI p- value
*1 2.24 Ref. — 2.58 Ref. — 77.16 Ref. —
*2 −0.08 (−0.58	to	0.41) .736 0.01 (−0.03	to	0.04) .9501 −2.81 (−13.29	to	7.67) .599
*3 −0.1 (−0.64	to	0.44) .711 −0.08 (−0.74	to	0.31) .695 0.7 (−10.72	to	12.12) .904
*4 −0.50 (−0.82	to	−0.18) .002 −0.36 (−0.61	to	−0.12) .003 −10.15 (−17.88	to	−2.42) .010
*5 −0.23 (−0.77	to	−0.31) .401 −0.19 (−0.58	to	0.21) .353 −1.74 (−13.19	to	9.71) .766
GSI,	global	symptoms	index;	PSDI;	Positive	Symptom	Distress	Index;	PST,	Positive	Symptom	Total;	Mean	diff,	mean	difference;	CI,	confidence	intervals;	
Ref.,	reference	haplotype.
F IGURE  2 Effect	of	TFAP2B–KCTD15	interaction	on	(a)	the	risk	for	AN;	(b)	the	risk	for	bulimia	nervosa	(BN);	(c)	weight	in	AN	patients;	 
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behaviors displayed by patients with psychiatric disorders are medi-
ated	by	 the	contribution	of	genes	 to	psychological	 traits	 (Cloninger,	
1999;	 Ebstein,	 Benjamin,	&	Belmaker,	 2000).	TFAP2B gene variants 
have previously been related to different personality dimensions in 




cent study has also observed an association between TFAP2B	SNPs	
and	obesity-	related	traits	(Albuquerque,	Nobrega,	Rodriguez-	Lopez,	&	




of	the	[CAAA]5 long allele in women with binge- eating disorders than 
in	controls	(Damberg	et	al.,	2001).	We	could	not	confirm	an	important	
role	of	 the	 [CAAA]4-5	SNP	 (rs370476693)	 in	 the	modulation	of	psy-
chopathological	 symptoms	 in	ED	patients;	however,	we	did	observe	
that	 rs552393576,	 an	A-	to-	G	 transition	 located	within	 the	 first	 re-
peat	of	this	polymorphism,	was	indeed	associated	with	certain	traits.	




mechanism linking this gene to these behaviors and specifically to 
ED?	These	personality	features	are	expressed	by	the	involvement	of	
a pattern of neuronal adaptations induced by central genes such as 
dopamine	or	serotonin,	which	has	been	consistently	associated	with	
ED-	coupled	 personality	 dimensions	 (Gervasini	 &	 Gamero-	Villarroel,	
2015).	 Dopaminergic	 and	 serotonergic	 genes	 in	 the	 midbrain	 have	
AP-	2	binding	sites;	 therefore	 it	 is	 likely	 that	 these	 transcription	 fac-
tors,	aside	from	its	established	role	during	development,	can	also	in-
fluence mood and personality in adults through this neurotransmitter 
system	(Damberg,	2005;	Damberg	et	al.,	2001).	In	the	same	manner,	
variability in the KCTD15	locus	could	play	its	role	by	altering	TFAP2B	
post-	translational	 modifications	 leading	 to	 orexigenic	 signaling	 and	
consummatory	behavior,	as	shown	in	Figure	1.





patients	 did	 not	 differ	 significantly,	 only	 rs2817420	was	 differently	
distributed	between	the	groups.	A	fact	that	stresses	this	similarity	in	
TFAP2B and KCTD15	genetic	variability	is	that	the	frequency	of	haplo-
type *6 in KCTD15 was significantly higher in controls but was similar 
between	obese	and	ED	patients.
An	interesting	finding	of	the	present	work	was	that	the	interaction	
between genetic variability in TFAP2B and KCTD15	was	linked	to	BN	
risk	as	well	as	correlate	with	weight	and	BMI	in	these	patients.	These	
results support previous reports suggesting a combined function of 
this	two	genes	(Zarelli	&	Dawid,	2013),	and	their	alleged	implication	





should additional personality traits were present. Their connection 
with	AN	would	however	be	more	intricate.
Several	 limitations	have	to	be	considered	 in	this	study.	First,	 the	
relatively small size of the population studied might affect the gener-
alizability	of	these	results.	However,	the	fact	that	the	study	was	per-
formed	in	the	only	primary	care	center	specialized	in	ED	in	the	area,	
allowed all the patients to be diagnosed and followed in the same facil-
ity	by	the	same	clinicians,	which	reduced	the	chance	that	the	findings	
may	be	due	to	population	structure.	Second,	we	could	not	determine	




Finally,	 it	would	have	been	 informative	 to	have	EDI-	2	and	SCL-	90R	
scores	 for	 the	control	population,	as	well	as	data	on	TFAP2B	5-	SNP	
haplotypes,	which	were	unfortunately	unavailable.




with anthropometric and psychological parameters in these patients. 
Further	studies	with	larger	and	homogeneous	populations	of	patients	
are nevertheless warranted to confirm the reported associations.
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